Merck

Last updated January 31, 2026

124

Innovation Areas

5,362

Inventors

Collaborations

Polynuclear metal complex crystalline host: MerckRecent Research Landscape

Off-target binding and poor metabolic stability in kinase inhibition lead to high drug failure rates. Precise substitution patterns on the quinazoline core optimize binding affinity and pharmacokinetic profiles to ensure therapeutic efficacy.

What technical problems is Merck addressing in Polynuclear metal complex crystalline host?

Inconsistent multi-phase analyte recovery

(4)evidences

Standard sampling systems fail to simultaneously collect both aerosolized and vaporized components from complex gaseous streams. Efficient capture of all fractions ensures accurate chemical analysis and process control in sensitive environments.